Sacroiliac Joint Interventions for Pain Management
Customize your policy alerts
Sign up for Arizona Complete Health Policy CP.MP.166 alerts
Get alerted when Policy CP.MP.166 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria, coding implications, and coverage stance for diagnostic and therapeutic sacroiliac joint injections and related procedures for members of Arizona Complete Health (Centene-affiliated plans). Applies to physician-performed invasive SIJ procedures using fluoroscopic or CT guidance.
No material clinical or coverage changes in this revision.
Coverage Criteria for SIJ Interventions
inv-01: Initial diagnostic or therapeutic SIJ injection — Covered when ALL of the following are met
Covered when ALL of the following are met
inv-02: Second confirmatory diagnostic SIJ injection — Covered when ALL of the following are met
Covered when ALL of the following are met
inv-03: Subsequent therapeutic SIJ injections for recurrence of pain — Covered when ALL of the following are met
Covered when ALL of the following are met
inv-04: Limits on duration — 1 top-level node
This policy covers diagnostic and therapeutic sacroiliac joint (SIJ) intra-articular injections performed by a physician using image guidance when the specified clinical criteria are met. Initial SIJ injection is covered when all entry criteria are satisfied (chronic nonradicular low back pain localized to the SIJ region, positive provocation testing, failure of conservative care, and absence of a more likely diagnosis). A second confirmatory diagnostic SIJ injection is covered only when the first diagnostic injection produced at least 75% pain relief and the required interval has elapsed. Subsequent therapeutic SIJ injections for recurrent pain are covered when prior therapeutic injection(s) provided ≥ 50% relief with functional improvement for at least two months, injections are given at least two months apart, and fewer than four therapeutic injections have been performed at the same site within a rolling 12‑month period. The policy states that continuation of injections beyond 12 months is generally considered not medically necessary except in narrowly justified, case‑by‑case situations.
State Medicaid program coverage provisions take precedence when they conflict with this clinical policy. For Medicare members, applicable Medicare National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs) and associated coverage articles (for example, LCDs referenced in the policy) should be consulted and applied as required.
Sacroiliac nerve blocks and radiofrequency neurotomy/ablation of nerves innervating the SIJ are not supported by this policy. Specifically, injections targeted to the nerves innervating the SIJ (e.g., CPT 64451) and radiofrequency ablation/neurotomy of SIJ‑innervating nerves (e.g., CPT 64625) are considered not medically necessary because effectiveness has not been established.
Relevant Procedure and Billing Codes
| 27096 | Injection procedure for sacroiliac joint, anesthetic/steroid, with image guidance (fluoroscopy or CT) including arthrography when performed |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
Prior Authorization, Documentation, and Provider Responsibilities
Imaging‑guided SIJ injection requires prior authorization and fluoroscopic/CT guidance
Fluoroscopic or CT‑guided sacroiliac joint (SIJ) injections (CPT 27096; HCPCS G0260) require prior review/authorization and are considered medically necessary only when the policy’s clinical criteria are met; imaging guidance must be fluoroscopy or CT and only one invasive pain procedure is allowed per visit.
Check Medicare NCDs/LCDs (including L39383) and Medicare guidance before applying criteria
Before applying this policy to Medicare members, providers should check applicable National and Local Coverage Determinations (including LCD L39383) and related Medicare coverage articles because Medicare coverage rules take precedence and the Health Plan may implement plan‑level prior authorization requirements.
- See CMS Local Coverage Determination L39383 for sacroiliac joint injections and procedures
- Refer to current Medicare coverage articles on the CMS website
- Health Plan determines effective date and may require prior authorization per plan rules
Document required conservative therapy trials prior to initial SIJ injection
Providers must document a trial of conservative therapy before an initial SIJ injection: at minimum ≥4 weeks of chiropractic, physical therapy, or a prescribed home exercise program; ≥3 weeks of NSAIDs (unless contraindicated); and ≥4 weeks of activity modification.
- Chiropractic, PT, or prescribed home exercise program ≥4 weeks
- NSAIDs ≥3 weeks or documentation of contraindication/intolerance
- Activity modification ≥4 weeks
Provider operational requirements — physician performance and one procedure per visit
Important operational note: procedures must be performed by a physician and only one invasive pain management procedure is allowed per visit; providers are expected to exercise professional medical judgment and follow Health Plan administrative policies.
- Procedures must be physician‑performed
- One invasive pain management procedure per visit
- Providers remain responsible for medical judgment and compliance with plan rules
Document justification to support continuation of SIJ injections beyond 12 months
Requests to continue SIJ injections beyond 12 months require documentation demonstrating severe functional or vocational disability, use of measurable baseline and follow‑up functional/ADL scales, evidence of ≥50% sustained pain relief and/or objective functional improvement for at least three months, and rationale (e.g., high surgical risk or refusal of surgery).
- Severity causing significant functional or vocational disability with measurable goals
- Baseline and follow‑up functional/ADL scales showing objective improvement
- At least 50% sustained and consistent pain relief and/or functional improvement for ≥3 months
- Clinical rationale for continuation (high surgical risk, patient refusal, etc.)
Ensure claims and documentation align with member coverage and Health Plan rules
When submitting claims, follow the member’s coverage documents and applicable Health Plan administrative policies and procedures; failure to comply with coverage terms, exclusions, limitations, or plan rules may affect payment.
- Adhere to evidence of coverage/certificate of coverage/policy contract terms
- Comply with state and federal requirements and Health Plan administrative policies
Denial risk if pain‑response or frequency thresholds are not met
Requests for additional SIJ injections may be denied if diagnostic pain relief thresholds are not met — specifically, a second diagnostic injection is not supported unless the first produced ≥75% pain improvement; subsequent therapeutic injections require prior documented ≥50% relief and functional improvement and interval/frequency criteria.
- Second diagnostic injection requires ≥75% pain improvement after first diagnostic injection and ≥2 weeks elapsed
- Subsequent therapeutic injections require ≥50% sustained relief and functional improvement for at least two months
- Frequency limits: injections ≥2 months apart and fewer than four therapeutic injections at same site per rolling 12 months
Coverage determinations subject to policy terms, exclusions, limitations, and applicable law
Coverage decisions and benefit administration are governed by the policy’s terms, conditions, exclusions, and limitations and by applicable state and federal requirements; adherence to these provisions is required for coverage determinations.
- Policy exclusions (e.g., sacroiliac nerve blocks and SIJ radiofrequency neurotomy are not medically necessary) apply
- State Medicaid rules and Medicare NCDs/LCDs take precedence when applicable
Noninvasive Care Required Before SIJ Procedures
inv-24: Must have failed conservative therapy prior to initial SIJ injection — specific trial durations (>=4 weeks PT/exercise; >=3 weeks NSAIDs)
Limits on Repeat Therapeutic SIJ Injections
Imaging Guidance and Technique for SIJ Procedures
Imaging guidance required for SIJ injections — fluoroscopy or CT
Imaging guidance is required for SIJ injections and must be performed with fluoroscopy or computed tomography (CT).
- Acceptable imaging guidance modalities: fluoroscopy or CT
- Imaging requirement applies to invasive SIJ procedures and is specified in policy I
Refer to clinical guidelines and LCDs for procedural imaging and technique
Refer to the cited clinical guidelines, systematic reviews, and CMS LCDs (e.g., L39383) for detailed procedural imaging and technique expectations; follow those sources in conjunction with this policy when performing and documenting SIJ procedures.
- See AHRQ CER No. 247, Cochrane review, and NASS guidance cited in references
- Consult CMS LCD L39383 for Medicare-specific procedural expectations
Clinical Background and Scope
Sacroiliac joint pain is an identifiable source of chronic low back pain in a substantial minority of patients. Conservative management (exercise programs, activity modification, nonsteroidal anti‑inflammatory drugs, manual therapy and physical therapy) is first‑line. Image‑guided intra‑articular SIJ injection can serve both diagnostic and therapeutic purposes for patients who have failed adequate conservative therapy; adding steroid to the injection may provide anti‑inflammatory benefit and prolong symptom relief. Fluoroscopic or CT guidance is required for invasive SIJ procedures per the policy.
Definitions and Reference Terms
Procedures Considered Not Medically Necessary
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.